tvt news Haberler
NEWYou can now listen to Fox News articles! An experimental drug has shown promise in fighting a hard-to-treat form of bladder cancer known as BCG-unresponsive high-risk non-muscle-invasive bladder cancer (NMIBC). BCG (Bacillus Calmette-Guérin) is an immunotherapy drug that is often the first-line treatment for certain early-stage bladder cancers. The new drug, TAR-200 — which was evaluated in a trial sponsored …
Read More »Some cancer patients could avoid surgery with innovative new therapy
